We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Pathology & Lab Medicine/Bệnh học

Pathology & Lab Medicine/Bệnh học

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Unraveling Abdominal Aortic Aneurysm: Epigenetic Links to Inflammation and Lipid Metabolism
CardiologyAbdominal Aortic AneurysmChuyển hóa mỡ máu

Unraveling Abdominal Aortic Aneurysm: Epigenetic Links to Inflammation and Lipid Metabolism

By MedXY|Oct 4, 2026

An epigenome-wide study reveals that DNA methylation markers linked to inflammatory pathways and blood lipid traits play a causal role in abdominal aortic aneurysm development, offering potential for improved risk prediction and therapeutic

Histopathologic Insights in Chronic Rhinosinusitis Linked to Intranasal Substance Use: Implications for Clinical Management
newsHistopathologyneutrophilic inflammation

Histopathologic Insights in Chronic Rhinosinusitis Linked to Intranasal Substance Use: Implications for Clinical Management

By MedXY|Sep 23, 2026

This study reveals distinct histopathologic features in chronic rhinosinusitis patients with intranasal substance use, highlighting increased neutrophilic inflammation and epithelial remodeling, underscoring the need for targeted clinical a

Enhanced Diagnosis of Primary Aldosteronism: Comparing LC-MS/MS and Immunoassay for Urinary Aldosterone Measurement
Diabetes & Endocrinologydiagnosisimmunoassay

Enhanced Diagnosis of Primary Aldosteronism: Comparing LC-MS/MS and Immunoassay for Urinary Aldosterone Measurement

By MedXY|Aug 30, 2026

This study demonstrates that urinary aldosterone measurement by LC-MS/MS outperforms immunoassay in diagnosing primary aldosteronism, especially when urinary sodium is within an optimal range, offering improved sensitivity and specificity f

Distinct Myeloid Landscapes Define Prognostic Niches in Extranodal NK/T-Cell Lymphoma
Hematology-OncologyMyeloid heterogeneityTumor Microenvironment

Distinct Myeloid Landscapes Define Prognostic Niches in Extranodal NK/T-Cell Lymphoma

By MedXY|Aug 27, 2026

Spatial multimodal profiling reveals two macrophage-defined ENKTL subgroups with distinct tumor-myeloid interactions influencing prognosis and potential immunotherapy targets.

Plasma POMC as a Predictive Biomarker for Silent Corticotroph Adenomas in Non-Functioning Pituitary Tumors
Diabetes & EndocrinologyACTH precursorsSilent corticotroph adenomas

Plasma POMC as a Predictive Biomarker for Silent Corticotroph Adenomas in Non-Functioning Pituitary Tumors

By MedXY|Aug 26, 2026

Elevated plasma pro-opiomelanocortin (POMC) levels accurately predict silent corticotroph adenomas (SCAs) among clinically non-functioning pituitary adenomas, offering a promising tool for diagnosis and monitoring.

Persistent High-Risk HPV Infection Without Major Cytological Abnormalities: Clinical Insights on Colposcopic and Histological Outcomes
newsColposcopyCervical Cancer Screening

Persistent High-Risk HPV Infection Without Major Cytological Abnormalities: Clinical Insights on Colposcopic and Histological Outcomes

By MedXY|Aug 22, 2026

Persistent high-risk HPV infection with normal or low-grade cytology carries a significant risk of high-grade cervical lesions, especially in younger women and those with atypical cytology. Colposcopy shows low sensitivity, urging careful b

Minimizing Myometrial Cell Spillage in Minimally Invasive Hysterectomy: Evaluating the Role of Contained Manual Morcellation
newspelvic washingscontained manual morcellation

Minimizing Myometrial Cell Spillage in Minimally Invasive Hysterectomy: Evaluating the Role of Contained Manual Morcellation

By MedXY|Aug 22, 2026

This study investigates whether contained manual morcellation during minimally invasive hysterectomy prevents myometrial cell spillage by analyzing sequential pelvic washings, revealing low spillage mostly occurring before morcellation.

New 2026 Multisociety Guidelines for Atypical Breast Lesions and LCIS: What Clinicians Need to Know
newsLCISAtypical Hyperplasia

New 2026 Multisociety Guidelines for Atypical Breast Lesions and LCIS: What Clinicians Need to Know

By MedXY|Aug 21, 2026

Multisociety 2026 guidance clarifies diagnosis and management of atypical breast lesions and lobular carcinoma in situ, balancing excision, surveillance, and chemoprevention based on lesion type, radiologic concordance, and risk.

Evaluating Cell-Free DNA Testing for Autosomal Recessive Conditions in General-Risk Pregnancies: A Multicenter Prospective Study
newsspinal muscular atrophyautosomal recessive

Evaluating Cell-Free DNA Testing for Autosomal Recessive Conditions in General-Risk Pregnancies: A Multicenter Prospective Study

By MedXY|Aug 17, 2026

This prospective multicenter study demonstrates that cfDNA fetal risk screening accurately identifies autosomal recessive conditions in general-risk pregnancies with high specificity and improved positive predictive value compared to tradit

Decoding Bone Marrow Architecture: A New Biomarker for Disease Activity and Treatment Response in Myelodysplastic Neoplasms
Hematology-Oncologymyelodysplastic neoplasmsbone marrow architecture

Decoding Bone Marrow Architecture: A New Biomarker for Disease Activity and Treatment Response in Myelodysplastic Neoplasms

By MedXY|Aug 17, 2026

Spatial remodeling of bone marrow in myelodysplastic neoplasms (MDS) reveals distinctive tissue-state signatures that better capture disease activity and predict therapeutic response beyond traditional blast counts.

Plasma Biomarkers for Neocortical Tau Burden
Neurologyタウ病理Plasma Proteins

Plasma Biomarkers for Neocortical Tau Burden

By MedXY|Aug 15, 2026

A multiprotein plasma panel improves detection of advanced neocortical tau pathology in Alzheimer’s disease risk individuals beyond p-tau217 alone, enhancing patient stratification and clinical trial selection.

Evaluating Antibody Detection Methods in Myasthenia Gravis: Insights from the ADAM Study
NeurologyAntibody TestingCell-Based Assays

Evaluating Antibody Detection Methods in Myasthenia Gravis: Insights from the ADAM Study

By MedXY|Aug 13, 2026

The ADAM Study demonstrates superior diagnostic accuracy of live cell-based assays over fixed cell-based and ELISA tests for detecting AChR antibodies in myasthenia gravis, highlighting important clinical implications for antibody testing s

Advancing Myasthenia Gravis Diagnosis: The Superior Accuracy of Cell-Based Assays in Antibody Detection
NeurologyAntibody TestingCell-Based Assay

Advancing Myasthenia Gravis Diagnosis: The Superior Accuracy of Cell-Based Assays in Antibody Detection

By MedXY|Aug 12, 2026

The ADAM study reveals that live and fixed cell-based assays outperform ELISA in detecting AChR and MuSK antibodies, offering enhanced diagnostic accuracy for myasthenia gravis, particularly in ocular cases.

Pathology and Genetics in a Global Cohort of Parkinsonian Disorders
Neurologypathologygenetics

Pathology and Genetics in a Global Cohort of Parkinsonian Disorders

By MedXY|Aug 12, 2026

This study analyzes clinicopathological and genetic correlations in Parkinsonian disorders across diverse ancestries, revealing diagnostic challenges, genetic influences, and ancestry-related pathological variations.

Silent Killers: Unveiling the Hidden Cardiac Pathologies Behind Sudden Cardiac Death
CardiologyOccult Cardiac Diseasesudden cardiac death

Silent Killers: Unveiling the Hidden Cardiac Pathologies Behind Sudden Cardiac Death

By MedXY|Aug 10, 2026

This study reveals that two-thirds of community sudden cardiac deaths occur in individuals without diagnosed cardiac disease, with half harboring occult myocardial infarction or dilated cardiomyopathy, underscoring the need for improved det

Evaluating Dried Blood Spot PCR for Detecting Congenital Cytomegalovirus in Newborns Identified by Targeted Testing
newscongenital cytomegalovirusPCR sensitivity

Evaluating Dried Blood Spot PCR for Detecting Congenital Cytomegalovirus in Newborns Identified by Targeted Testing

By MedXY|Aug 4, 2026

This cohort study assesses the sensitivity and clinical relevance of dried blood spot PCR testing for congenital CMV in infants identified through expanded targeted screening, highlighting diagnostic strengths and limitations for universal

How to Evaluate a Sinonasal Mass: Key Recommendations from a Multidisciplinary Consensus
newsbiopsyimaging

How to Evaluate a Sinonasal Mass: Key Recommendations from a Multidisciplinary Consensus

By MedXY|Jul 20, 2026

A practical summary of a 2026 multidisciplinary consensus on the proper evaluation and workup of sinonasal masses, emphasizing when to image, when to biopsy, pathology needs, and special-population considerations.

Decoding Placental Pathology Risks in Dichorionic Twins: Ultrasound Phenotypes of Fetal Growth Impairment
newsPlacental Pathologyultrasound phenotypes

Decoding Placental Pathology Risks in Dichorionic Twins: Ultrasound Phenotypes of Fetal Growth Impairment

By MedXY|Jul 20, 2026

This study identifies distinct placental pathology risks across ultrasound-defined fetal growth phenotypes in dichorionic twins, proposing risk categories to guide clinical management and future research on late-onset fetal growth restricti

Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning
Cardiologycardiovascular riskLDL-C estimation

Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning

By MedXY|Jul 18, 2026

This study introduces and validates a simplified machine learning-based equation for estimating LDL cholesterol, showing comparable accuracy to the original Martin-Hopkins method and improved ease of use.

Discriminating Prion Diseases from Alzheimer’s Disease Using Plasma Biomarkers: The Crucial Role of NfL/p-tau217 Ratio
NeurologyAlzheimer's diseaseDấu hiệu sinh học huyết tương

Discriminating Prion Diseases from Alzheimer’s Disease Using Plasma Biomarkers: The Crucial Role of NfL/p-tau217 Ratio

By MedXY|Jul 14, 2026

Plasma phosphorylated tau biomarkers overlap in Alzheimer’s and prion diseases, risking diagnostic confusion. The NfL/p-tau217 ratio emerges as an accurate plasma biomarker to distinguish prion diseases from Alzheimer’s, improving diagnosti

1 / 3
123
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Browse by specialty

Open language-specific specialty feeds and department pages.

news7212 articlesCardiology1442 articlesClinical Updates1357 articlesOncology1236 articlesDiabetes & Endocrinology916 articlesNeurology874 articlesPublic Health630 articlesGastroenterology613 articles
Hematology-Oncology
555 articles
Pediatrics529 articles
Internal Medicine477 articles